HIV CD4/Viral Load Monitoring Intervals
Evidence-based guide to CD4 count and viral load monitoring frequency in people living with HIV (PLHIV) on antiretroviral therapy (ART). Based on BHIVA HIV monitoring guidelines 2023. Helps determine appropriate review intervals.
Score interpretation
Pre-treatment or early ART: frequent monitoring required
→ Baseline: CD4, VL, FBC, U&E, LFT, glucose, lipids, HLA-B*57:01, resistance genotype, Hep B/C, syphilis, STI screen, TB screen; CD4 + VL at 1 and 3 months after ART start; VL target <50 copies at 6 months; continue 3-monthly until VL stable; cervical smear (women); review adherence at every visit
On ART with VL <50 for >12 months — reduced monitoring acceptable
→ Annual CD4 count (can omit if CD4 >500 for >2 years and VL consistently <50); viral load every 6 months (or annually if very stable per clinician judgement); annual lipids, glucose, renal, LFT; STI screen annually (or per risk); annual blood pressure, weight, cardiovascular risk; flu vaccine annually; 3-yearly smear; ophthalmology if CD4 ever <100
VL >200 or low-level viraemia — virological failure or blip
→ Repeat VL in 4 weeks; assess adherence thoroughly; resistance genotype testing if confirmed VL >500; review drug interactions; HIV specialist review; consider ART switch if resistance confirmed; target VL <50 copies within 3–6 months of regimen change; psychosocial adherence support; review for intercurrent illness; CD4 every 3 months until stable
Interpretation bands for the HIV CD4 Monitoring. Apply clinical judgement and local guidance.
References
- BHIVA. Guidelines for the treatment of HIV-1 positive adults with antiretroviral therapy 2023. British HIV Association.
Related
Curated clinical cross-links plus same-class fallbacks.
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Sodium Chloride 3% (Hypertonic Saline) · Hypertonic Electrolyte Solution — ICP/Hyponatraemia Management
- Lopinavir / Ritonavir · HIV Protease Inhibitor (Boosted) — Antiretroviral Therapy
- Letermovir · CMV Antiviral — Viral Terminase Inhibitor (Prophylaxis in HSCT)
- Dolutegravir · Integrase strand-transfer inhibitor (INSTI) — antiretroviral
- Zidovudine · NRTI (antiretroviral)
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.